CiteFacts · FDA Drug Shortages · FDA source
Dextrose Monohydrate 70% Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| B. Braun Medical Inc. | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) | Available | 08/07/2026 |
| Baxter Healthcare | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06) | Unavailable | 08/17/2026 |
| Otsuka ICU Medical LLC | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07) | Available | 08/17/2026 |
| Otsuka ICU Medical LLC | DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19) | Available | 08/17/2026 |
Source facts
Grouped generic ingredient: Dextrose Monohydrate 70% Injection · 4 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.